Medical Economics November 16, 2023
Urology group leader explains why now is the time to reconsider USPSTF recommendations on screening in men.
Prostate cancer is a leading cause of cancer death in American men, and it’s time to revisit the guidelines to test for it, said the leader of a national urology group.
This fall, the U.S. Preventive Services Task Force (USPSTF) solicited comments about its “Prostate Cancer: Screening” recommendation. It’s an early step in the review process that could lead to changes to the recommendation dating from 2018.
Then, USPSTF gave a “C” grade to screening men aged 55 to 69, so the decision to be screened for prostate cancer should be an individual one. The Task Force recommended against prostate specific antigen-based (PSA)...
Today's Sponsors
Today's Sponsor